VISUAL OUTCOMES AND CLINICAL FEATURES OF EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN

Letícia de Oliveira Audi1, Ricardo A P de Carvalho2, Antônio M Casella3

  • 1Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

PubMed
Summary

Extensive macular atrophy with pseudodrusen (EMAP) is linked to rheumatic fever complications. Early diagnosis and treatment of rheumatic fever may impact EMAP progression and visual outcomes.